首页|基于高通量测序技术对脑卒中相关性肺炎多重耐药病原微生物分析

基于高通量测序技术对脑卒中相关性肺炎多重耐药病原微生物分析

扫码查看
目的 通过高通量测序技术分析脑卒中相关性肺炎(SAP)感染组织中病原微生物特点,明确多重耐药(MDR)的情况,为临床肺组织感染病原菌的鉴定及治疗提供快速、准确的方法。方法 从2022年1月-2023年12月于本院治疗的SAP患者中,选取130例发生MDR者作为研究对象,采集所有患者呼吸道样本,应用高通量测序技术进行病原微生物的鉴定,明确菌群特点,同时进行药敏试验,分析MDR情况;另选取30例SAP未发生MDR的患者作SAP组,比较分析诱发SAP患者发生MDR的危险因素。结果 130例SAP发生MDR患者,共检出189株病原菌,其中革兰阴性杆菌99株,革兰阳性球菌占30。16%,真菌占11。64%及其他类型的细菌或微生物占5。82%。革兰阴性杆菌主要耐药性:嗜麦芽窄食单胞菌对头孢他啶、替卡西林、美罗培南的耐药率均在60%以上,其中对替卡西林的耐药率达80%;粘质沙雷菌对头孢他啶、头孢噻吩氨曲南的耐药率>60%;肺炎克雷伯菌对头孢他啶、头孢噻吩、头孢曲松和头孢吡肟超过60%;革兰阳性球菌主要耐药性:金黄色葡萄球菌对青霉素G、苯唑西林、氨苄西林、替考拉宁的耐药率均在60%以上,其中青霉素G耐药率最高占(75%);屎肠球菌对青霉素G、苯唑西林、红霉素、氨苄西林、万古霉素的耐药率均超过75%,其中对青霉素G、氨苄西林、红霉素、万古霉素的耐药率大于80%;肺炎链球菌对青霉素G、苯唑西林、红霉素、复方磺胺甲噁唑、氨苄西林的耐药率均超过65%,对青霉素G、苯唑西林耐药率占比高(83。33%)。经Logistic回归分析结果显示,年龄(大)、预防抗生素使用(有)、感染菌种类型(≥2种)、糖尿病史是诱发SAP患者发生MDR的危险因素(P<0。05)。结论 高通量测序技术可较准确的鉴定出SAP感染组织中病原微生物及菌群特征,耐药位点检测全面,且有扩展性,优势显著,临床应用推广性高。
The multi-drug resistant pathogenic microorganisms of stroke-associated pneumonia will be analyzed using high-throughput sequencing technology
Objective This study aims to employ high-throughput sequencing technology to analyze the characteristics of pathogenic microorganisms in stroke-associated pneumonia(SAP)infected tissues,elucidate the extent of multi-drug resistance(MDR),and establish a rapid and accurate method for identifying and treating pathogens in clinical lung tissue infections.Methods From January 2022 to December 2023,a total of 130 patients with MDR infections were selected as the subjects for this study.Respiratory tract samples were collected from all patients,and high-throughput sequencing technology was utilized to identify pathogenic microorganisms to elucidate bacterial characteristics.Additionally,drug sensitivity testing was conducted to analyze the MDR profiles.Another group of 30 SAP patients without MDR infections was selected as the control group,allowing for comparison and analysis of risk factors associated with MDR in SAP patients.Results A total of 189 strains of pathogens were detected in 130 SAP patients with MDR,including 99 strains of gram-negative bacilli,accounting for 30.16%of Gram-positive cocci,accounting for 11.64%of fungi,and accounting for 5.82%of other types of bacteria or microorganisms.Primary drug resistance of Gram-negative bacilli:The rates of drug resistance in Stenotrophomonas maltophilia to ceftazidime,ticarcillin,and meropenem exceeded 60%,with the resistance rate to ticarcillin reaching up to 80%.The resistance rate of Serratia marcescens to ceftazidime and cefthienaztreonam was greater than 60%.Over 60%of Klebsiella pneumoniae isolates exhibited resistance towards ceftazidime,cephalothin,ceftriaxone,and cefepime.Primary resistance of Gram-positive cocci:The resistance rates of Staphylococcus aureus to penicillin G,oxacillin,ampicillin,and teicoplanin exceeded 60%,with the highest resistance rate observed for penicillin G(75%).The resistance rates of Enterococcus faecium to penicillin G,oxacillin,erythromycin,ampicillin,and vancomycin were over 75%,while the resistance rates to penicillin G,ampicillin,erythromycin,and vancomycin surpassed 80%.Streptococcus pneumoniae exhibited drug resistance rates exceeding 65%against penicillin G,oxacillin,erythromycin compound sulfamethoxazole,and ampicillin;notably high drug resistance was observed for penicillin G and oxacillin(83.33%).The results of the Logistic regression analysis revealed that advanced age,positive use of prophylactic antibiotics,presence of two or more types of infection bacteria,and a history of diabetes were identified as significant risk factors for MDR infections in patients with SAP(P<0.05).Conclusion High-throughput sequencing technology can precisely identify pathogenic microorganisms and bacterial flora characteristics in SAP-infected tissues,comprehensively detecting drug-resistance sites.With significant advantages and expandability,it is highly recommended for clinical applications.

high-throughput sequencing technologystrokestroke-associated pneumoniamulti-drug resistancepathogenic microorganisms

陶智、李仙丽、刘琼

展开 >

武汉市新洲区人民医院检验科,湖北武汉 431400

高通量测序技术 脑卒中 脑卒中相关性肺炎 多重耐药 病原微生物

2025

中国病原生物学杂志
中华预防医学会,山东省寄生虫病防治研究所

中国病原生物学杂志

北大核心
影响因子:1.219
ISSN:1673-5234
年,卷(期):2025.20(2)